CHAPTER 1 - HEMOSTASIS PART 7 Flashcards
must be avoided
Hemolysis
Rbc contains(platelet activator)
ADP
May cause premature activation of
platelet if released in the plasma
Hemolysis
is the anticoagulant of choice (except for glass bead retention test)
Citrate
pH is very critical and easily affected by recapping method
Citrate
pH is best controlled by this buffer
Citrate
glass bead retention test should
contain
heparin
sample (anticoag) → 60-100 x g → 10 minutes Plasma → plastic/siliconized test tube
Platelet Rich Plasma (PRP) preparation
stored in RT (not refrigerated nor incubated)
Platelet Rich Plasma (PRP) preparation
red cell contamination = hemolysis = release of ADP
Platelet Rich Plasma (PRP) preparation
upper layer that is not touching the red cell
Platelet Rich Plasma (PRP) preparation
sample (remains) → 2000 x g for 10 minutes Plasma → plastic/siliconized test tube
Platelet Poor Plasma (PPP) preparation
layer almost in contact w/ the red cell
Platelet Poor Plasma (PPP) preparation
upper 3⁄4 layer
Platelet Poor Plasma (PPP) preparation
-samples are centrifuged at 2-4 deg celcius
beta-Thromboglobilin (bTG) and PF4 determinations
cold (not RT)
beta-Thromboglobilin (bTG) and PF4 determinations
most stable b/w:
30 minutes to 3 hours
performed 1st
-Ristocetin
plt responds to ristocetin will decerase as the pH of the plasma changes
-Ristocetin
as soon as blood is exposed to air after centri, blood pH will start to decrease, hence aggregation will be affected
-Ristocetin
performed last
Epinephrine
response w/ plt increases w/ time
Epinephrine
tales 60 mins to take effect
Epinephrine
: more sensitive to aggregating agents than @ 37 deg cel
platelets @ room temp
sensitive to RT making them more aggregatable than inside the body
platelets @ room temp
plts prepared for aggregation studies
due to sensitivity to various
aggregating agents
platelets @ room temp
spontaneous aggregation
platelets @ 0-4 deg
beta-Thromboglobilin (bTG) and PF4
determinations
platelets @ 0-4 deg
Measures the ability of the small blood vessels to control bleeding after injury
. Bleeding time
Factors affecting BT
: number of platelets and the ability of platelets to form (?); Thickness and vascularity of the skin and the ability of the blood vessels to (?) may also affect results.
plugs
constrict
Prolonged: when platelet count is lower than (?)or when platelets are dysfunctional.
: in Vwd
: after ingestion of aspirin/aspirin-containing compounds, anti-inflammatory, anticoagulants, and some antibiotics
30 - 50, 000/uL
Puncture is done on the earlobe. bleeding ceases.
Duke method
Reference value: 1 - 3 mins
Duke method
Done on the forearm; Standard pressure applied is 40 mmHg
Ivy method
• Reference value: 1 - 7 mins.
Ivy method
Uses a template containing a standardized slit
Template BT (by Mielke)
Platelet adhesiveness/Retention Test
→ Reference values:
26% - 60%
3 substances required by platelet to adhere successively:
Ionized Calcium, Fibrinogen, ADP
- (?) is not required in vitro/initial adhesion, but required for longer retention and accurate measurement, along w/ ADP
VWF
: involves the formation of plt aggregates in the column (long rubber tubing) where platelet adhesion test will take place; measurement of retained platelets
- Retention
enhances plt retention
RBC
→ Collect 2 whole blood samples, 1 using EDTA and the other using glass bead collecting system.
Glass Bead Method/Salzman Method
Perform platelet counts separately. (higher in EDTA
Glass Bead Method/Salzman Method
-Collect in 2 tubes (EDTA and glass bead collecting system)
Glass Bead Method/Salzman Method
- Counts are higher in EDTA
Glass Bead Method/Salzman Method
→ Perform separate platelet count on venous blood and capillary blood samples. % = plate count aust our Vet count callary blood x 100
Borshgervinct Method (in vivo test)
→ Clinical Significance of platelet adhesiveness
Borshgervinct Method (in vivo test)
⁃ Glanzmann’s thrombasthenia; Chediak
Decrease platelet adhesiveness
- Higashi syndrome
Decrease platelet adhesiveness
⁃ Some myeloproliferative disorders; Uremia
Decrease platelet adhesiveness
⁃ Ingestion of aspirin and other drugs
Decrease platelet adhesiveness
⁃ Venous thrombosis; Pulmonary embolism; Carcinoma
Increase platelet adhesiveness
⁃ During pregnancy; Following splenectomy; Oral contraceptive intake
Increase platelet adhesiveness
-Involves platelet count on venous and capillary blood samples.
Borshgervinct Method (in vivo test)
-Venous Thrombosis
INCREASE
-Pulmonary Embolism
INCREASE
-Carcinoma
INCREASE
-During pregnancy
INCREASE
-Splenectomy
INCREASE
-Oral contraception
INCREASE
-Glanzmann’s Thrombasthenia
DECREASE
-Chediak
DECREASE
Higashi
DECREASE
Myeloproliferative disorders
DECREASE
Uremia
DECREASE
-Aspirin and other drugs
DECREASE
Aggregating agents:
thrombin, arachidonic acid, ADP, collagen,
epinephrine and ristocetin
→ Currently, this test is considered the gold standard for evaluation of aspirin resistance
Platelet Aggregation Test
Principle of Aggregation
Aggregating agents added to a stirred suspension of (?) induce a shape change and aggregation of platelets. As a result, the PRP changes from a turbid suspension to one that transmits more light (clear) as the aggregates are formed. The aggregometer records changes in (?) in the form of a graph.
PRP
optical density
Aggregating agents added to PRP→ induces shape change and aggregation → PRP changes from turbid to clear (transmits more light) as aggregates are
formed → optical density is recorded
by aggregometer.
Principle of Aggregation
:light-transmittance aggregometer
Platelet-Rich Plasma Aggregometry
: electrical impedance
Whole-Blood Platelet Aggregometry
for simultaneous measurement of platelet aggregation and the secretion of ATP
Optical Lumi-Aggregometer.
Tests the ability of small capillaries to retain blood when subjected to increased hydrostatic pressure and
anoxia.
Tourniquet test/Capillary Fragility test)
Nonspecific screening test
Tourniquet test/Capillary Fragility test)
Principle: an inflated blood pressure cuff on the upper arm is used to apply pressure to the capillaries for 5 minutes.
Rumple-Leede Method (Positive pressure)
The forearm, hands and fingers are then examined for petechiae
Rumple-Leede Method (Positive pressure)
Rumple-Leede Method (Positive pressure) Normal:
0 to occasional petechiae
uses positive pressure
Rumple-Leede Method (Positive pressure)
A suction cup (diameter) is placed in close contact with the skin at midpoint of upper arm for (?). An area within a circle of (?) diameter is observed for petechiae (?) after removal of suction cup.
Hess/Suction test (Negative pressure)
2-cm
1 min (pressure of 200 - 250 torr)
1 cm
5 minutes
Hess/Suction test (Negative pressure)
● Clinical significance: Positive in
thrombocytopenia, hypofibrinogenemia and in vascular purpura.
● -uses negative pressure
Hess/Suction test (Negative pressure)
-Uses suction cup (2-cm diameter) → midpoint of upper arm → 1 min (200-
250 torr) → 1 cm diameter area is observed after 5 minutes of suction cup removal
Hess/Suction test (Negative pressure)
Clot Retraction Principle: When blood coagulation is complete, clot normally undergoes retraction where clot becomes denser and serum is expressed. Normally, clot retraction begins within (?) after the blood has clotted & complete within (?)
30 minutes
24 hours.
● Normal clot retraction requires
normal number of functioning platelets, Ca*, ATP, fibrinogen, normal interaction of the platelets with fibrinogen
- ratio of the plasma volume and red cell mass; activity of a retraction-promoting principle in serum
& nature of the surface on which CRT
is being measured.
Thrombosthenin
Clinical significance: CRT is poor
when platelet count is less than 100,000/uL; in dysfibrinogenemia or hypofibrinogenemia, paraprotinemias
Clot Retraction
Qualitative: Test for the presence or
absence of retraction
Hirschboeck Method (Castor oil Method)
● Formation of dimpling/droplet like
serum on the surface of blood drop
Hirschboeck Method (Castor oil Method)
● Normal Values = 15 - 45 minutes
Hirschboeck Method (Castor oil Method)
● Normal: clot retraction begins within 1
hour, complete within 18 to 24 hours
Stefanini Method (Test tube)
● Provides quantitative estimate of the degree of retraction
Mac Farlane Method
● Normal Values = 44% - 67 %
Mac Farlane Method
• Sodium citrate - anticoagulant
Tocantins Method (Rees -Ecker diluting fluid composition)
• Formalin - fixative; prevent premature lysis (preserves both red cells and platelets)
Tocantins Method (Rees -Ecker diluting fluid composition)
• BCB - stains the platelets
Tocantins Method (Rees -Ecker diluting fluid composition)
• Brecker - Cronkite Method (Diluent: 1% NH4 oxalate)
Phase - Contrast Microscopy Method
• Counting chamber: Spencer — Briteline # 1475
Phase - Contrast Microscopy Method
• Platelets are counted in 5 R squares
Phase - Contrast Microscopy Method
• Uses EDTA and ammonium oxalate Diluent
Composition:
Unopette Method
0.44% NHa oxalate; 0.22% K: EDTA; 0.75% Crystal Violet
• Uses 14% MgSO4 as diluent
Fonio’s Method